A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A

Part of paid clinical trials in Iowa City, Iowa.

Sponsor
Novo Nordisk A/S
Study ID
NCT07830732
Phase
PHASE3
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Haemophilia A

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Denecimig — DRUG
    Participants will receive subcutaneous (s.c.) injections of denecimig.

Study Details

The purpose of this study is to find out if denecimig is safe and effective for treating people who have acquired haemophilia A. Participants will be in this study for up to around 1 year and 5 months (73 week).

Key Dates

First listed
Sep 21, 2026
Start date
Oct 9, 2026
Status verified
Sep 2026
Primary completion
Mar 23, 2029
Completion
Mar 23, 2029

Study Design

Enrollment
84 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Denecimig
    Denecimig will be administered subcutaneously.

Primary Outcome Measure

Number of treated bleeds [ Time Frame: From treatment initiation (week 0) until end of main part (week 12) ]

Central Contacts

Locations (18)

FacilityCityStateZIPSite coordinators
University of Iowa_Iowa CityIowa CityIowa52242-
Tulane University School of MedicineMetairieLouisiana70001-
University of MinnesotaMinneapolisMinnesota55455-
Mayo ClinicRochesterMinnesota55905-
Washington UniversitySt LouisMissouri63110-
University of North CarolinaChapel HillNorth Carolina27614-
Duke University_DurhamDurhamNorth Carolina27710-
University of Oklahoma HealthOklahoma CityOklahoma73104-
Penn State MS Hershey Med CtrHersheyPennsylvania17033-2360-
Univ of Pennsylvania HospitalPhiladelphiaPennsylvania19104-
UT SouthwesternDallasTexas75390-
Univ Texas HSC-HoustonHoustonTexas77030-
UT Health San AntonioSan AntonioTexas78229-
University of Utah HealthSalt Lake CityUtah84106-
University of Vermont Med CtrBurlingtonVermont05401-
University of VirginiaCharlottesvilleVirginia22903-
Virginia Cwealth Univ RichmondRichmondVirginia23298-
Washington Ctr Bleed DisorderSeattleWashington98195-

Find similar trials in Iowa City, IA

By research site
University of Iowa_Iowa City· Iowa City, IATulane University School of Medicine· Metairie, LAUniversity of Minnesota· Minneapolis, MNMayo Clinic· Rochester, MNWashington University· St Louis, MOUniversity of North Carolina· Chapel Hill, NC

Related Studies